BridgeBio Pharma, Inc., a leading biopharmaceutical firm, is slated to participate in the prestigious Goldman Sachs 46th Annual Global Healthcare Conference 2025. BridgeBio, founded in 2015, is at the forefront of discovering, creating, testing, and delivering transformative medicines for patients suffering from genetic diseases. The company announced that their management team will be partaking in […]